DK1311486T3 - Anvendelser af thaliporphin eller dets derivater til behandling af hjertesygdomme og fremstilling af samme - Google Patents

Anvendelser af thaliporphin eller dets derivater til behandling af hjertesygdomme og fremstilling af samme

Info

Publication number
DK1311486T3
DK1311486T3 DK01921112T DK01921112T DK1311486T3 DK 1311486 T3 DK1311486 T3 DK 1311486T3 DK 01921112 T DK01921112 T DK 01921112T DK 01921112 T DK01921112 T DK 01921112T DK 1311486 T3 DK1311486 T3 DK 1311486T3
Authority
DK
Denmark
Prior art keywords
thaliporphine
derivatives
treatment
applications
preparation
Prior art date
Application number
DK01921112T
Other languages
Danish (da)
English (en)
Inventor
Mingjai Su
Shoeisheng Lee
Original Assignee
Lotus Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/644,932 external-priority patent/US6313134B1/en
Application filed by Lotus Pharmaceutical Co Ltd filed Critical Lotus Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1311486T3 publication Critical patent/DK1311486T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK01921112T 2000-08-23 2001-02-28 Anvendelser af thaliporphin eller dets derivater til behandling af hjertesygdomme og fremstilling af samme DK1311486T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/644,932 US6313134B1 (en) 2000-05-04 2000-08-23 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same

Publications (1)

Publication Number Publication Date
DK1311486T3 true DK1311486T3 (da) 2006-09-04

Family

ID=24586946

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01921112T DK1311486T3 (da) 2000-08-23 2001-02-28 Anvendelser af thaliporphin eller dets derivater til behandling af hjertesygdomme og fremstilling af samme

Country Status (19)

Country Link
EP (1) EP1311486B1 (el)
JP (1) JP2004506719A (el)
KR (1) KR100522008B1 (el)
CN (1) CN1176909C (el)
AT (1) ATE325099T1 (el)
AU (2) AU2001248226B2 (el)
BR (1) BR0111761A (el)
CA (1) CA2412170C (el)
CY (1) CY1105432T1 (el)
DE (1) DE60119336T2 (el)
DK (1) DK1311486T3 (el)
ES (1) ES2260209T3 (el)
HU (1) HUP0301971A3 (el)
IL (1) IL153205A (el)
MX (1) MXPA02012316A (el)
PT (1) PT1311486E (el)
RU (2) RU2350326C2 (el)
WO (1) WO2002016325A1 (el)
ZA (1) ZA200209965B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843963B1 (fr) * 2002-08-30 2004-10-22 Sederma Sa Nouvelles molecules derivees de la noraporphine
JP2006527699A (ja) * 2003-06-19 2006-12-07 美時化学製薬股▲ふん▼有限公司 アポルフィン、及び、ケトンアポルフィン化合物とその用途
US20140155609A9 (en) * 2010-11-24 2014-06-05 Dong-A St Co., Ltd. Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757335C3 (de) * 1977-12-22 1982-03-25 Gödecke AG, 1000 Berlin Verfahren zur O-Methylierung von Hydroxyaporphinen
DE3118521A1 (de) * 1981-05-09 1982-12-02 Gödecke AG, 1000 Berlin Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien
JPS6416722A (en) * 1987-07-13 1989-01-20 Tsumura & Co Blood viscosity lowering agent

Also Published As

Publication number Publication date
CN1429212A (zh) 2003-07-09
KR100522008B1 (ko) 2005-10-18
RU2350326C2 (ru) 2009-03-27
CA2412170A1 (en) 2002-02-28
HUP0301971A2 (hu) 2003-09-29
DE60119336D1 (de) 2006-06-08
EP1311486A4 (en) 2004-03-31
HUP0301971A3 (en) 2007-09-28
BR0111761A (pt) 2003-06-24
IL153205A (en) 2007-06-17
AU2001248226B2 (en) 2004-07-08
CN1176909C (zh) 2004-11-24
EP1311486A1 (en) 2003-05-21
CA2412170C (en) 2007-01-02
KR20030009533A (ko) 2003-01-29
DE60119336T2 (de) 2007-05-10
ATE325099T1 (de) 2006-06-15
JP2004506719A (ja) 2004-03-04
RU2005140373A (ru) 2007-06-27
AU4822601A (en) 2002-03-04
RU2002133099A (ru) 2004-05-10
ZA200209965B (en) 2004-03-09
CY1105432T1 (el) 2010-04-28
ES2260209T3 (es) 2006-11-01
IL153205A0 (en) 2003-07-06
PT1311486E (pt) 2006-09-29
EP1311486B1 (en) 2006-05-03
WO2002016325A1 (en) 2002-02-28
MXPA02012316A (es) 2005-04-19

Similar Documents

Publication Publication Date Title
CY1105127T1 (el) Συνθεση για την προληψη καρδιαγγειακων νοσων
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
JP2003520232A5 (el)
WO2005063734A3 (de) Substituierte thiophene
ATE556059T1 (de) Pyrazolderivate zur behandlung von hiv
BR0012243A (pt) Triflúor butenos nematocidas
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
DE60205888D1 (de) Das citrat-salz des 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaens
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
NO20030802D0 (no) Aminoalkoksybenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme
YU60101A (sh) Derivati rezorcinola
DK1311486T3 (da) Anvendelser af thaliporphin eller dets derivater til behandling af hjertesygdomme og fremstilling af samme
UY28630A1 (es) Prevención y tratamiento de enfermedades cardiacas hipertensivas mediante el uso de lso estrógenos selectivos 8b(beta) -vinil-estra-1,3,5 (10)-trien-3, 17b(beta)-diol y 17b(beta) -fluor-9a(alfa)-vinil-estra-1,3,6(10)-trien-3,16a(alfa)-diol
IL161116A (en) Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary arterial hypertension
AU2001265876A1 (en) Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
DK1253935T3 (da) Anvendelse af placenta-vækstfaktor til forebyggelse eller behandling af iskæmiske sygdomme eller slagtilfælde
BRPI0509740A (pt) compostos para tratamento das arritmias cardìacas e métodos de uso
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
NO20030801D0 (no) Aminoalkenylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme
CL2004001461A1 (es) Compuestos derivados de 1,2,3,4-tetrahidropirimidina, composicion farmaceutica y su procedimiento de preparacion, procedimiento de preparacion, utiles para tratar o prevenir la hepatitis c.
ITTO20020138A0 (it) Composti estere, procedimenti di lotta contro insetti nocivi e utilizzi dei composti estere.
ATE315038T1 (de) Antibakterielle mittel
CA2512952A1 (en) Depigmentation agents